These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18572226)

  • 1. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score.
    Brun JL; Rouzier R; Uzan S; Daraï E
    Gynecol Oncol; 2008 Sep; 110(3):354-9. PubMed ID: 18572226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.
    Fagotti A; Ferrandina G; Fanfani F; Ercoli A; Lorusso D; Rossi M; Scambia G
    Ann Surg Oncol; 2006 Aug; 13(8):1156-61. PubMed ID: 16791447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.
    Fagotti A; Ferrandina G; Fanfani F; Garganese G; Vizzielli G; Carone V; Salerno MG; Scambia G
    Am J Obstet Gynecol; 2008 Dec; 199(6):642.e1-6. PubMed ID: 18801470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of a laparoscopic-based score to evaluate resectability for patients with advanced ovarian cancer undergoing interval debulking surgery.
    Chereau E; Lavoue V; Ballester M; Coutant C; Selle F; Cortez A; Daraï E; Leveque J; Rouzier R
    Anticancer Res; 2011 Dec; 31(12):4469-74. PubMed ID: 22199317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer.
    Fagotti A; Vizzielli G; Costantini B; Lecca A; Gallotta V; Gagliardi ML; Scambia G; Fanfani F
    Acta Obstet Gynecol Scand; 2011 Oct; 90(10):1126-31. PubMed ID: 21707553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of hand-assisted laparoscopy in predicting resectability of peritoneal carcinomatosis from gynecological malignancies.
    Varnoux C; Huchon C; Bats AS; Bensaid C; Achouri A; Nos C; Lécuru F
    Eur J Surg Oncol; 2013 Jul; 39(7):774-9. PubMed ID: 23597496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advanced ovarian cancer: criteria of resectability].
    Chéreau E; Ballester M; Rouzier R; Coutant C; Daraï E
    Bull Cancer; 2009 Dec; 96(12):1189-97. PubMed ID: 19919915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.
    Chi DS; Venkatraman ES; Masson V; Hoskins WJ
    Gynecol Oncol; 2000 May; 77(2):227-31. PubMed ID: 10785469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: "External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score".
    Fagotti A; Francesco F; Giovanni S
    Gynecol Oncol; 2009 Jan; 112(1):284-5; author reply 286. PubMed ID: 18922565
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of computed tomography in the staging and predicting resectability of primary advanced ovarian carcinoma].
    Lou FL; Shi YF
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):701-5. PubMed ID: 17274380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study to evaluate the utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer.
    Gilani MM; Karimi Zarchi M; Ghaemmaghami F; Behtash N; Mousavi AS; Ansaripoor S
    Gynecol Oncol; 2007 Jun; 105(3):780-3. PubMed ID: 17433423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
    Bristow RE; Duska LR; Lambrou NC; Fishman EK; O'Neill MJ; Trimble EL; Montz FJ
    Cancer; 2000 Oct; 89(7):1532-40. PubMed ID: 11013368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer.
    Chéreau E; Ballester M; Selle F; Cortez A; Daraï E; Rouzier R
    Am J Obstet Gynecol; 2010 Feb; 202(2):178.e1-178.e10. PubMed ID: 20113693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of laparoscopy in predicting surgical outcomes in patients undergoing interval cytoreduction surgery for advanced ovarian carcinoma: A prospective validation study.
    Tomar TS; Nair RP; Sambasivan S; Krishna KMJ; Mathew A; Ahmed IM
    Indian J Cancer; 2017; 54(3):550-555. PubMed ID: 29798957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer.
    Bozkurt N; Yuce K; Basaran M; Kose F; Ayhan A
    Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer.
    Gemer O; Lurian M; Gdalevich M; Kapustian V; Piura E; Schneider D; Lavie O; Levy T; Fishman A; Dgani R; Levavi H; Beller U
    Eur J Surg Oncol; 2005 Nov; 31(9):1006-10. PubMed ID: 16005601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of hand-assisted laparoscopy in ovarian cancer.
    Krivak TC; Elkas JC; Rose GS; Sundborg M; Winter WE; Carlson J; MacKoul PJ
    Gynecol Oncol; 2005 Jan; 96(1):72-6. PubMed ID: 15589583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma.
    Littell RD; Hallonquist H; Matulonis U; Seiden MV; Berkowitz RS; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):570-4. PubMed ID: 16769104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept.
    Petrillo M; Vizzielli G; Fanfani F; Gallotta V; Cosentino F; Chiantera V; Legge F; Carbone V; Scambia G; Fagotti A
    Gynecol Oncol; 2015 Oct; 139(1):5-9. PubMed ID: 26196319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma?
    Angioli R; Plotti F; Capriglione S; Aloisi A; Montera R; Luvero D; Miranda A; Cafà EV; Damiani P; Benedetti-Panici P
    Gynecol Oncol; 2013 Mar; 128(3):579-83. PubMed ID: 23220563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.